CLINICAL_TRIALS
trial_result
· 2016-09-27
Clinical Trial Update: Smoking Relapse Prevention in Schizophrenia [Phase 4]
Summary
This clinical trial update reports a Phase 4 study on preventing smoking relapse in individuals with schizophrenia or schizoaffective disorder, which has comple…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: North Suffolk Mental Health Association | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED